Anthem Biosciences Limited (NSE:ANTHEM)
India · Delayed Price · Currency is INR 858.50
-0.10 (-0.01%)
Oct 1, 2026, 3:29 PM IST
Anthem Biosciences Market Cap
Anthem Biosciences has a market cap or net worth of 481.95 billion as of October 2, 2026. Its market cap has increased by 12.74% in one year.
Market Cap
481.95B
Enterprise Value
473.11B
Revenue
20.07B
Ranking
n/a
PE Ratio
84.66
Stock Price
858.50
ChartMarket Cap Chart
Since July 21, 2025, Anthem Biosciences's market cap has increased from 410.17B to 481.95B, an increase of 17.50%. That is a compound annual growth rate of 14.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 481.95B | 31.72% |
| Dec 31, 2025 | 365.89B | -10.80% |
| Jul 21, 2025 | 410.17B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biocon | 602.96B |
| OneSource Specialty Pharma | 174.45B |
| Concord Biotech | 143.70B |
| Blue Jet Healthcare | 101.84B |
| Supriya Lifescience | 76.48B |
| Zota Health Care | 44.84B |
| Dishman Carbogen Amcis | 24.69B |
| Panacea Biotec | 22.42B |